Androgen-related symptoms like acne, facial hair growth, or scalp hair thinning, and insulin resistance appears to be part of the driver
Lonza provided the carnitine tartrate capsules and part of the salary of one of the co-authors (P
Questo dato conferma indirettamente che il calo ponderale che si registra nei pazienti in trattamento con GLP-1RA frutto di una perdita di massa grassa e non di massa muscolare
doi: 10.3389/fendo.2024.1379228 Received 30 January 2024 Accepted 08 April 2024 Published 30 April 2024 Volume 15 - 2024 Edited by Fabrizio Barbetti, University of Rome Tor Vergata, Italy Reviewed by Xavier Prieur, INSERM U1087 Institut du Thorax, France Joseph Polex-Wolf, Novo Nordisk, Denmark Updates Copyright 2024 Roumane, Mcilroy, Sommer, Han, Heisler and Rochford
Patients generally have to wait until the medication reaches a steady state and they notice significant changes in their blood sugar levels, appetite suppression, and body weight
And the researchers who published it aren't writing editorials saying "maybe worry about this someday" - they're calling for DXA baselines, resistance training, and protein optimization to become standard of care from day one of GLP-1 therapy